Navitor Pharmaceuticals is based in Cambridge. It has raised $103M in total funding.
Navitor Pharmaceuticals funding overview
Navitor Pharmaceuticals is based in Cambridge. Navitor Pharmaceuticals has raised $103M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Investors on record include SR One Capital Management, Brace Pharma, Sanofi-Genzyme BioVentures, Johnson & Johnson Development Corporation, Polaris Partners, Atlas Venture and 2 others. 8 distinct backers are named across the disclosed rounds.
Navitor Pharmaceuticals at a glance
Total raised
$103M
Headquarters
Cambridge
Notable investors
SR One Capital Management, Brace Pharma, Sanofi-Genzyme BioVentures, Johnson & Johnson Development Corporation, Polaris Partners, Atlas Venture, Remeditex Ventures, Longevity Fund
Frequently asked about Navitor Pharmaceuticals funding
How much has Navitor Pharmaceuticals raised?
Navitor Pharmaceuticals has raised $103M in total disclosed funding across the rounds on record.
Who has invested in Navitor Pharmaceuticals?
SR One Capital Management, Brace Pharma, Sanofi-Genzyme BioVentures, Johnson & Johnson Development Corporation, Polaris Partners, Atlas Venture are named among the investors backing Navitor Pharmaceuticals.
What was the latest Navitor Pharmaceuticals funding round?
No round stage has been disclosed for Navitor Pharmaceuticals.
Where is Navitor Pharmaceuticals based?
Navitor Pharmaceuticals is based in Cambridge.
Navitor Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
